More exposure
|
5
|
Resverlogix Corp.
|
May 20, 2021 11:39AM
|
Market reaction to SGLT2i and Jardiance?
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 12:58PM
|
Managing Covid Expectations
|
5
|
Resverlogix Corp.
|
May 09, 2022 02:03PM
|
IR response
|
10
|
Resverlogix Corp.
|
Jan 11, 2022 02:21PM
|
IR response
|
8
|
Resverlogix Corp.
|
May 04, 2022 03:37PM
|
IR responded (quickly!)
|
5
|
Resverlogix Corp.
|
Dec 02, 2021 12:48PM
|
in the event of breakthrough...
|
6
|
Resverlogix Corp.
|
Dec 11, 2019 12:07PM
|
Hepalink...
|
4
|
Resverlogix Corp.
|
Feb 11, 2020 12:37AM
|
Hepa...
|
6
|
Resverlogix Corp.
|
Aug 05, 2020 10:32PM
|
Hepa / ORI
|
5
|
Resverlogix Corp.
|
Oct 30, 2020 11:13AM
|
Hepa
|
1
|
Resverlogix Corp.
|
Jun 23, 2020 11:00PM
|
Good grief
|
4
|
Resverlogix Corp.
|
Feb 04, 2021 11:51AM
|
GAC: Volume? Dark Volume?
|
|
Resverlogix Corp.
|
Dec 09, 2019 10:04PM
|
Forest plot
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 12:11PM
|
For those who missed it live...
|
9
|
Resverlogix Corp.
|
May 12, 2021 10:40PM
|
For the sake of the argument...
|
5
|
Resverlogix Corp.
|
Sep 27, 2020 10:48PM
|
FDA meeting confirmed
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 11:19AM
|
Ethics Approval?
|
3
|
Resverlogix Corp.
|
Oct 12, 2021 04:49PM
|
eGFR and Cognition?
|
8
|
Resverlogix Corp.
|
Nov 22, 2019 11:47AM
|
EFGR!!!
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 02:13PM
|